AAV Emerges in Boy Using Levamisole to Treat Kidney Disease

AAV Emerges in Boy Using Levamisole to Treat Kidney Disease

327851

AAV Emerges in Boy Using Levamisole to Treat Kidney Disease

ANCA-associated vasculitis (AAV) emerged as a side effect of levamisole given for years to treat a 15-year-old boy with idiopathic nephrotic syndrome, according to a case report. “By reporting this case, we want to raise awareness among clinicians regarding a rare complication of treatment with Levamisole that is often misdiagnosed due to the fact that the current literature lacks univocal guidelines regarding the precise timing of ANCA titrations and the duration of the treatment,” the…

You must be logged in to read/download the full post.